The extracellular domain of receptor protein tyrosine phosphatase b (RPTPb) is composed of several domains which mediate its interactions with distinct ligands present on the surface of either neurons or glial cells. Here, we demonstrate that the ®bronectin type III domain (FNIII) of RPTPb binds to glial tumor-derived cell lines and primary astrocytes. We used anity puri®cation to isolate several proteins that speci®cally bind to the FNIII domain of RPTPb. One of these, a 240 kDa protein that was puri®ed from U118MG glioblastoma cell, was identi®ed as tenascin C based on the amino acid sequence of several tryptic peptides. The interaction of RPTPb with tenascin C was found to mediate cell adhesion. Adhesion and spreading of SF763T astrocytoma cells expressing RPTPb on tenascin C was speci®cally abolished by the addition of a soluble fragment containing the FNIII domain of the receptor. RPTPb-dependent cell adhesion was mediated by binding to the alternatively spliced FNIII repeats A1,2,4 (TnfnA1,2,4) of tenascin C. Furthermore, COS cells expressing RPTPb adhere to TnfnA1,2,4, while the parental cells did not. These results demonstrate that the FNIII domain of RPTPb binds to tenascin C and suggest that RPTPb present on glial tumor cells is a primary adhesion receptor system to the extracellular matrix. Oncogene (2001) 20, 609 ± 618.
Introduction
The interactions between tumor cells and the extracellular matrix is important for neoplastic transformation and cell invasion. Protein tyrosine phosphorylation regulates various signal transduction pathways underlying fundamental cellular processes such as cell motility, growth and dierentiation (Angers-Loustau et al., 1999; Neel and Tonks, 1997; Stoker and Dutta, 1998) . The extracellular domain of most of the known receptor-like protein tyrosine phosphatases (RPTPs) shares structural similarities with cell adhesion molecules suggesting that they play a role in cell-cell and cell-matrix communication by directly coupling cell recognition events to signal transduction pathways within the cell Schaapveld et al., 1997; Zondag and Moolenaar, 1997) .
Receptor protein tyrosine phosphatase b (RPTPb, also known as RPTPz) contains in its extracellular domain a region with sequence homology to the enzyme carbonic anhydrase (CAH), followed by a ®bronectin type III repeat (FNIII) and by a long unique sequence termed the spacer domain (Krueger and Saito, 1992; Levy et al., 1993) . Three dierent isoforms of RPTPb are generated as a result of alternative splicing: a short and a long receptor form that dier by the absence or presence of a stretch of 860 amino acid residues in the spacer domain, and a third secreted form composed of the extracellular domain of the long receptor known also as phosphacan, 6B4 and DSD-1 proteoglycans (Barnea et al., 1994; Garwood et al., 1999; Levy et al., 1993; Maeda et al., 1994) . Both the long receptor form and phosphacan are found in rat brain as chondroitin sulfate proteoglycans, whereas the short receptor form (dvRPTPb) is lacking glycosaminoglycan side chains (Sakurai et al., 1996) . RPTPb is predominantly expressed in the nervous system where it is mainly found in glial precursors, radial glia and astrocytes , as well as in certain neurons (Snyder et al., 1996) . The expression of the dierent forms of RPTPb is regulated during development of the glial lineage. Early in development, high levels of the receptor forms are found in proliferating precursor cells at the subventricular zones. As development progresses and cells mature, these receptor forms are replaced by the secreted non-phosphatase form (Canoll et al., 1996; Sakurai et al., 1996) . The short receptor form of RPTPb is found in certain astrocytomas and glioblastomas and may represent transformed early proliferating glial precursors (Krueger and Saito, 1992; Sakurai et al., 1996) . RPTPb is also found in human cutaneous melanomas which developmentally originate from the neural crest (Goldmann et al., 2000) .
The dierent forms of RPTPb bind to multiple ligands Peles et al., 1998; Oohira et al., 2000) . It has been previously shown that phosphacan interacts directly with the neuronal recognition molecules N-CAM, Ng-CAM and TAG-1 (Milev et al., 1996) , with the extracellular matrix molecules tenascin C and tenascin R (Barnea et al., 1994; Grumet et al., 1994; Milev et al., 1995; Xiao et al., 1997) , and with several heparin-binding growth factors, including HB-GAM (Maeda et al., 1996) amphoterin (Milev et al., 1998a) and bFGF (Milev et al., 1998b) . In contrast, the nonproteoglycan short receptor form was found to interact with the GPI-linked molecule contactin (Peles et al., 1995) and with lower anity with Ng-CAM, Nr-CAM and N-CAM (Sakurai et al., 1997) . The multifunctional interaction of phosphacan and RPTPb with dierent ligands involves dierent domains of the receptor and, at least for phosphacan, depends on the presence of chondroitin sulfate or is mediated by N-linked oligosaccharides (Peles et al., 1998) .
Tenascin C is a multifunctional protein that has been implicated in glial cell adhesion and migration (Giese et al., 1996; Zagzag et al., 1995) . Although the direct interaction between phosphacan and tenascin C suggests a novel mechanism for matrix-cell signaling and raises the possibility that RPTPb may modulate cell adhesion, it is presently unknown whether, like phosphacan, the short receptor form also binds to extracellular matrix proteins such as tenascin C. This is of particular interest as the short receptor form is found in early migratory glial precursors and in tumor cells (Canoll et al., 1996) . We have previously found that while the CAH domain of RPTPb binds to contactin present in neurons, the FNIII domain of this phosphatase may bind a distinct ligand present on the surface of glial cells (Peles et al., 1995) . Here we extend these observations and identify this glial ligand as tenascin C. The interactions between RPTPb and tenascin C mediate the adhesion of glial tumor cells and involve the FNIII domains of both molecules.
Results

The FNIII domain of RPTPb mediates its binding to glial cells
The extracellular domain of RPTPb is composed of several domains that mediate its interactions with distinct ligands that are present in neuronal and nonneuronal cells (Peles et al., 1998) . To further identify such ligands, we produced soluble proteins that contained dierent subdomains of RPTPb fused to human IgG ( Figure 1a ). These recombinant proteins were used in binding experiments using glioblastoma (U251MG, U373MG, C6) and astrocytoma (SF763T, U118MG) cell lines. As depicted in Figure 1b , all constructs containing the FNIII domain of RPTPb bound well to these cell lines. No binding was detected with the carbonic anhydrase domain (bC), the spacer region (bS), or when an Fc-fusion protein containing the carbonic anhydrase and the FNIII domains of the related phosphatase RPTPg was used (Figure 1b and data not shown). Similar results were obtained using cultured primary astrocytes (Figure 2a) . Staining of GFAP-positive astrocytes with bF-Fc revealed a punctate staining pattern on the surface of the cells ( Figure   2b ). In agreement with our binding analysis, no staining of astrocytes was detected with bC-Fc. In contrast, bCFc intensely labeled few oligodendrocytes that were occasionally present in the cultures. Given that contactin is expressed by oligodendrocytes (Koch et al., 1997) , it is likely that this staining represents the interaction between the carbonic anhydrase domain of RPTPb and contactin in these cells (Peles et al., 1995) . Previous in situ hybridization and immunohistochemistry data suggested that RPTPb is expressed by astrocytes (Canoll et al., 1996) . As depicted in Figure 2b , we con®rmed the presence of the receptor form of RPTPb in our cultures by staining with anti-RPTPb speci®c antibody, as well as with a contactin-Fc fusion protein. Altogether, these analyses revealed the presence of a speci®c ligand for the FNIII domain of RPTPb on the surface of various glialderived cell lines and primary cultured astrocytes.
Identification of a glial ligand for RPTPb
In order to isolate a ligand for the FNIII domain of RPTPb from glial cells, membrane proteins were prepared from 35 S-methionine-labeled cell lines and incubated with bF-Fc or bC-Fc as a control ( Figure  3a) . Several distinct sets of proteins speci®cally bound to the bF-Fc anity matrix from the dierent cell lines. In SF763T and C6 cells, bF-Fc precipitated four proteins with the apparent molecular weight of 160, 170, 200 and 210 kDa, while two proteins of 220 and 240 kDa were detected from U138MG and U118MG cells. These proteins were not detected using bC-Fc, indicating that they interact speci®cally with the FNIII domain of RPTPb. Furthermore, bF-Fc precipitated these proteins only from glial-derived, but not from several neuroblastoma (neuro 2A and H4) or neuroendocrine (GH3) cell lines. In contrast, bC-Fc precipitated a 140 and a 190 kDa proteins from GH3 that were identi®ed as contactin and Caspr respectively (Peles et al., 1995 . We next used bF-Fc to purify the 240 kDa protein from U118MG cells (Figure 3b ). The 240 kDa protein was excised from the gel, digested with trypsin and the resulting peptides were separated by HPLC (data not shown). Selected peptides were analysed by automated Edman degradation. The sequence of one of the peptides (PVLSAEASTGETPNLGEVV) was identical to positions 1151 ± 1169 of human tenascin C (accession #P24821). All other sequenced peptides were also derived from human tenascin C (data not shown). Furthermore, we have con®rmed the identity of both the 220 and 240 kDa proteins isolated by bF-Fc from U118MG cells as tenascin C by immunoblot analysis (Figure 3c ). In conclusion, the FNIII domain of RPTPb binds to several distinct ligands present in glial cells, two of which were identi®ed as isoforms of the extracellular matrix protein tenascin C. The identity of the other proteins is yet to be determined.
RPTPb is expressed in glial tumor cell lines
The identi®cation of tenascin C as a glial ligand for RPTPb raises the possibility that it may modulate the binding of RPTPb present in these cells with other ligands. We ®rst examined the expression of RPTPb in the various cell lines. Immunoblot analysis revealed that the short receptor form of RPTPb was found in U251MG, SF763, SF763T, U373MG, C6 and SF767T ( Figure 4a ). No expression of RPTPb transcript or protein was detected in U118MG ( Figure 4a and b) or U138MG cells (data not shown), the two cell lines from which tenascin C was precipitated by bF-Fc. We next compared the cell surface expression of RPTPb in several cell lines using a speci®c antibody against its extracellular domain with the binding of a soluble contactin-Fc, a known ligand of the carbonic anhydrase domain (Peles et al., 1995) . As depicted in Figure  4c , strong binding of anti-RPTPb antibody was detected in SF763T, C6, U251MG and U373MG cells, indicating that RPTPb is expressed on the surface of these cells. However, in contrast to the antibody binding which was equivalent in all RPTPb-expressing cells, we observed higher levels of Contactin-Fc binding I-labeled protein A as described in Materials and methods. An average of two sets of experiments done in triplicates is shown to SF763T and C6 cells than to U251MG and U373MG. Given that U251MG and U373MG, but not the SF763T and C6 cell lines we used produce tenascin C (Figure 4d ), these results may suggest that the binding of contactin to RPTPb is modulated by tenascin C binding to RPTPb in cells which express both proteins.
RPTPb mediates adhesion of SF763T cells to tenascin C
Tenascin C is an extracellular matrix component that is implicated in cell adhesion and migration (Faissner, 1997; Jones and Jones, 2000) . To determine the functional consequence of the binding of RPTPb to tenascin C, we have performed a series of adhesion assays. As shown in Figure 5 , SF763T cells adhere and spread on polystyrene dishes precoated with either laminin or tenascin C. Adhesion of SF763T cells to tenascin C occurred within less than a minute of plating and did not require calcium (data not shown). No adhesion was observed on an uncoated surface (Figure 6 ), or when BSA was used as a substrate (data not shown). Cell adhesion and spreading on tenascin C, but not on laminin, was completely inhibited by the addition of a soluble Fc-fusion protein containing the carbonic anhydrase and the FNIII domains of RPTPb. In contrast, an Fc-fusion protein containing the carbonic anhydrase and the FNIII domains of the highly related RPTPg, as well as a fusion protein containing the CAH domain of RPTPb, had no eect on cell adhesion ( Figure 6 and data not shown). Furthermore, the eect of the FNIII domain of RPTPb on adhesion to tenascin C was speci®c to cells that express this receptor. For example, although U118MG cells that do not express RPTPb adhere to tenascin C, this adhesion was not eected by the addition of soluble RPTPb fusion proteins (data not shown). These results demonstrate that RPTPb mediates adhesion of SF763T cells to tenascin C.
SF763T adhesion involves two distinct domains of tenascin C
In order to examine which domain of tenascin C is involved in RPTPb-dependent cell adhesion, we have used various recombinant domains of the protein as a substrate. As shown in Figure 6 , SF763T cells adhere and spread on FNIII domains 1-3 (TNfn1-3) and FNIII domains A1,A2,A4 (TnfnA1,2,4). No adhesion of SF763T cells was detected when the EGF, ®brinogen, or several other FNIII domains of tenascin C were used as a substrate. We next examined whether adhesion of SF763T cells to Tnfn1-3 or TnfnA1,2,4 could be inhibited by the addition of a soluble bCF-Fc. As shown in Figure 7 , bCF-Fc completely abolished adhesion and cell spreading on tenascin C and on TnfnA1,2,4, but not when Tnfn1-3 was used as a substrate.
We next determined whether expression of RPTPb in transfected cells will enable cell adhesion to the TnfnA1,2,4 domains of tenascin C. As depicted in Figure 8 , COS-7 cells adhere to tenascin C, as well as to its ®rst three FNIII repeats (Tnfn1-3), but not to its TnfnA1,2,4 domains. In contrast, COS-7 cells expressing the short receptor form of RPTPb, also adhere and spread when the TnfnA1,2,4 domains of tenascin C were used as a substrate. Furthermore, similar to SF763T cells, the adhesion of RPTPb-transfected cells to the TnfnA1,2,4, but not to Tnfn1-3 could be blocked by the addition of a soluble bF-Fc fusion protein (data not shown). Altogether, these results demonstrate that the short receptor form of RPTPb functions as a cell adhesion receptor for tenascin C. (Walzel et al., 1999) . RPTPs were also found to interact with cell adhesion molecules present on the same plane of the plasma membrane to create multi-protein complexes (Fashena and Zinn, 1997; Zeng et al., 1999) and to regulate cell adhesion (Shenoi et al., 1999) . Finally, studies demonstrating that several RPTPs interact with cytoskeletal proteins SerraPages et al., 1995 SerraPages et al., , 1998 further support the possible role of these receptors as mediators of cell ± matrix interactions. We have previously shown that various domains found in the short receptor form of RPTPb dierentially mediate the binding of this receptor to distinct ligands found in neurons and glial cells (Peles et al., 1995) . The carbonic anhydrase-like domain of RPTPb interacts with the neuronal GPI-linked cell adhesion molecule contactin, leading to cell adhesion and neurite outgrowth of contactin-expressing cells. In the present study, we have identi®ed the glial ligand that binds the FNIII domain of RPTPb as tenascin C. We further show that glial-derived tumor cells expressing this receptor adhere and spread on tenascin C, suggesting that RPTPb function as an adhesion molecule.
Does the binding of tenascin C to RPTPb modulate the interaction of this receptor with other ligands? Tenascin C is a multi-domain protein, which interacts with several adhesion systems including members of the Ig-superfamily neuronal adhesion molecules (Milev et al., 1996 ; Zisch et al., 1992), integrins (Giese et al., S-methionine-labeled H4 neuroglioma, SF763T, C6, U138MG and U118MG glioblastomas, and Neuro 2A neuroblastoma cells were subjected to precipitation with bC-Fc (C) or bF-Fc (F) as indicated at the top (ECD). The protein complexes were washed as described in Materials and methods and resolved on SDS ± PAGE. Autoradiogram of the gel is shown along with the location of molecular weight markers in kDa. The FNIII domain precipitated dierent sets of proteins from glial but not neuro-derived cell lines. The 140 and 190 kDa proteins precipitated by bC-Fc GH3 cells represent contactin and caspr complex. The 220 ± 240 kDa protein from U118MG membranes (shown in b) was used for protein sequencing. (c) Identi®cation of the 220 and 240 kDa proteins precipitated with bF-Fc as tenascin C isoforms. Solubilized membrane proteins from U118MG cells were subjected to precipitation with bC-Fc, bF-Fc, or an antibody to tenascin C (aTenascin C) as indicated at the top of each lane, followed by immunoblot with an antibody against tenascin C. Membrane lysate (membrane) and puri®ed tenascin C (Tenascin C) were used as control 1996; Phillips et al., 1998; Prieto et al., 1993; Schnapp et al., 1995; Yokosaki et al., 1998) , phosphacan (Barnea et al., 1994; Grumet et al., 1994; Milev et al., 1995 Milev et al., , 1997 and the short receptor form of RPTPb (this study). Both tenascin C and RPTPb interact with contactin (Peles et al., 1995; Revest et al., 1999; Zisch et al., 1992) , suggesting that the binding of each pair (i.e., RPTPb-contactin, RPTPb-tenascin and contactintenascin) could potentially be regulated by the presence of the third component. Whether such regulation occurs competitively or cooperatively may depend on which speci®c domain within each protein is directly involved in binding. It has been shown that the ®rst Ig domains in contactin mediate its binding to both tenascin C and phosphacan (Revest et al., 1999; Zisch et al., 1992) . In contrast, contactin, phosphacan and RPTPb bind to distinct sites in tenascin C. While contactin binds to the ®fth and sixth ®bronectin repeats of tenascin C (TNfn5-6) (Jones and Jones, 2000) , and phosphacan binds to its ®brinogen domain (Milev et al., 1997) , the short receptor for of RPTPb interacts with TNfnA1,2,4. We have shown that two distinct sites in RPTPb, the carbonic anhydrase and its FNIII domains mediate its binding to contactin and tenascin C, respectively (Peles et al., 1995; and this study) . However, although RPTPb could potentially bind contactin and tenascin simultaneously, we have observed reduced binding of contactin to cells which express both RPTPb and tenascin C. This result suggests that the presence of tenascin may negatively regulate the binding of contactin to RPTPb, and argue against the presence of a stable tertiary complex. This Immunoprecipitation and immunoblot analyses were done using antibody against tenascin C as described in (a) for RPTPb is further supported by recent ®ndings which have detected contactin-phosphacan and contactin-tenascin C, but not a tertiary complex that contains all of these molecules in rat brain (Revest et al., 1999) . Taken together, these results suggest that the function of the short receptor form of RPTPb in cell adhesion is highly regulated by a complex interplay of other cell adhesion molecules and extracellular matrix components such as tenascin C.
We show that expression of the short receptor form of RPTPb in COS-7 cells results in adhesion of these cells to the TNfnA1,2,4 domains of tenascin C, indicating that this phosphatase functions as a receptor system for cell adhesion. Previous experiments showed that the third FNIII repeat of tenascin C mediates cell binding through interaction with integrins (Prieto et al., 1993; Schnapp et al., 1995; Yokosaki et al., 1998) . These interactions were also reported to be important for astrocytes adhesion and astrocytoma and glioma migration (Giese et al., 1996; Phillips et al., 1998) . Using dierent domains of tenascin C as a substrate, we have found that adhesion of SF763T cells is mediated by TNfn1-3 and TNfnA1,2,4. Although these two distinct sites are involved in SF763T adhesion, only the adhesion on TnfnA1,2,4 could be inhibited by the FNIII domain of Figure 5 RPTPb-dependent adhesion of SF763T cells to tenascin C. Polystyrene dish that had been precoated with tenascin C (TnC; upper panels), or laminin (Lam; lower panels) was further incubated with an Fc-fusion containing the carbonic anhydrase and the FNIII domains of RPTPb (bCF), RPTPg (gCF), the FNIII domain of RPTPb (bF), or BSA (7) as indicated. SF763T cells (1610 5 cells) were placed in the central region of the dish for 1 h and non-adhered cells were removed by gentle washing. The plate was ®xed and viewed using inverted microscope. Magni®cation:620 Figure 6 Adhesion of SF763T cells is mediated by two distinct sites in tenascin C. (a) Schematic representation of tenascin C and the dierent recombinant tenascin C fragments used in this study. (b) Adhesion of SF763T cells to dierent tenascin C domains. The indicated fragments (10 mg/ml) were bound to a polystyrene dish and adhesion assay was carried out exactly as described in the legend to Figure 5 . Two distinct regions of tenascin C FNIII repeats mediated cell adhesion. While Tnfn1-3 is found in all known tenascin C proteins, TnfnA1,2,4 are alternatively spliced FNIII repeats that are inserted between the ®fth and the sixth FNIII repeats only in several isoforms of tenascin C. Magni®cation:620
RPTPb. Similar speci®city was observed using COS-7 cells which express RPTPb. Thus, it appears that adhesion of these cells is mediated by binding of RPTPb to TNfnA1,2,4, and by binding of TNfn1-3 to another receptor system, most likely to integrins. Moreover, given that a soluble bFc also inhibits the adhesion of these cells to a full-length tenascin C molecule which contains both the TNfn1-3 and TNfnA1,2,4 domains, it is likely that the interactions of RPTPb with tenascin C regulates cell adhesion mediated by other receptor systems. An additional receptor may be annexin II which is involved in epithelial and endothelial cell attachment by binding to TnfnA1,2,4 (Chung et al., 1996) . One possible convergent point between RPTPb and other adhesion receptor signaling may be via Rho family of small GTPases, which were recently shown to be regulated by tenascin C (Wenk et al., 2000) . Whether RPTPb aects Rho activation is yet to be determined.
It has been previously shown that adhesion of glioblastoma cells to tenascin C is modulated by the secretion of phosphacan (Sakurai et al., 1996; Milev et al., 1997) . Thus, a unique feature of this adhesion system is that it is regulated by the presence of the short receptor form of RPTPb on the cell surface, as well as by the secretion of its proteoglycan form phosphacan. Given the high expression of tenascin C at the edges of glial tumors (Zagzag et al., 1995) , this may have important implications for the progression of the disease. The extracellular matrix of glial tumors is involved in a variety of cell functions, such as cell attachment, migration and proliferation, which are mediated by complex interactions with cell surface receptors. The modulation of the interactions between RPTPb and tenascin C would represent one example by which tumor cells remodel their environment by regulating their binding to extracellular matrix proteins.
Materials and methods
Proteins and antibodies
Production and puri®cation of the dierent Ig-fusion was performed as described previously (Peles et al., 1995; Sakurai et al., 1997) . The following recombinant human Ig-fusion proteins containing dierent domains of the extracellular regions of dvRPTPb were used: bC (amino acids from 1 ± 313), bCF (amino acids from 1 ± 415), bF (amino acids from 301 ± 414), bCFS (amino acids from 1 ± 630), bFS (amino Figure 7 Identi®cation of TnfnA1,2,4 as an RPTPb-dependent adhesion site for glioblastoma cells. Polystyrene dishes were coated with 10 mg/ml tenascin C (TnC), TnfnA1,2,4, or the Tnfn1-3 fragments as indicated on the top. The prepared substrates were subsequently incubated with BSA control (7, upper panels), or with the Fc-fusion containing the carbonic anhydrase and the FNIII domains of RPTPb (bCF, middle panels), or the FNIII of RPTPb alone (bF, lower panels). Following blocking with BSA, SF763T cells were placed in the center of the dish and incubated for one hour. Non-adhered cells were removed by three washes and bound cells were ®xed and photographed using a phase-contrast inverted microscope. Magni®cation:620 Figure 8 Expression of RPTPb in COS cells results in cell adhesion to the TnfnA1,2,4 domains of tenascin C. COS-7 cells were transfected with RPTPb (COS-RPTPb) or without DNA (COS) were allowed to adhere to dishes precoated with either tenascin C (TnC), ®bronectin, TnfnA1,2,4, or TNfn1-3 as indicated. After 1 h, non-adhered cells were removed by gentle washing and bound cells were ®xed and viewed using inverted microscope. Magni®cation:620 acids from 301 ± 630), and bS (amino acids from 415 ± 630). The generation of recombinant tenascin C fragments was previously described (Scholze et al., 1996) . Puri®ed tenascin was a generous gift from Dr Martin Grumet.
Monoclonal antibodies to RPTPb were purchased from Transduction Laboratories, Cy3 and FITC-conjugated secondary antibodies were from Jackson laboratory, anti GFAP from Sigma and anti-tenascin C antibody (AB1906) from Chemicon. Polyclonal antibody to the extracellular domain of RPTPb was obtained by immunizing mice with puri®ed bCFIg protein and clearing the serum from anti-human Fc antibodies by passing it through a normal human IgGSepharose column.
Cell culture
Growth and origin of the dierent cell lines used in this study were previously described (Peles et al., 1995) . For culturing rat astrocytes, the cortex of newborn rat pups was dissected and dissociated by incubation with 0.25% trypsin (Gibco) and collagenase (Sigma) for 20 min. Cells were washed several times in DMEM+10% fetal calf serum and triturated with a pasteur pipette. The cells were plated at 100 000 cells/ cm 2 in 75 cm 2 Primaria¯asks (Falcon) and grown in DMEM+10% fetal calf serum. After 8 days, con¯uent cultures were shaken for 14 h at 37C8 to remove oligodendrocyte precursors and the attached cells were trypsinized and replated. For immuno¯uorescence, cells were grown on glass coverslips precoated with 10 mg/ml polylysine for 3 days before the experiment.
Protein purification and sequencing
Analytical scale puri®cation using the Ig-fusion proteins as anity reagents was performed from 35 S methionine-labeled cells as previously described . In certain cases the complexes were resolved on an SDS gel and subjected to Western blotting with anti-tenascin C antibody. Immunoprecipitation and immunoblotting (Poliak et al., 1999) and protein puri®cation were done essentially as described previously (Peles et al., 1995) .
Ig fusion proteins and antibody binding and immunofluorescence
Binding of Ig-fusion proteins to cultured cell lines was done as described previously (Peles et al., 1995) . Similar protocol was used for antibody binding experiments but 125 I-labeled anti-mouse IgG was used instead of protein-A. For staining experiments, astrocytes grown on coverslips in a 24-well dish were incubated with conditioned media containing the various Ig-fusion proteins for 2 h at ambient temperature. The dish was placed on ice and unbound material was removed by three consecutive washes with cold PBS. Slides were ®xed with 4% paraformaldehyde in 0.1 M phosphate buer for 30 min and subsequently stained with Cy3-conjugated anti-human Fc antibody as described previously (Poliak et al., 1999) . Immuno¯uorescence slides were viewed and analysed using a Deltavision wide-®eld deconvolution system (Applied Precision) connected to Zeiss¯uorescence microscope.
Cell adhesion assays
SF763T cells were removed from the tissue culture plate by washing with PBS containing 10 mM EDTA, washed once with DMEM containing 4% BSA and resuspended in DMEM/F12. 1610 5 cells in 0.5 ml of binding buer were placed in the central region of 35 mm polystyrene dish that had been precoated with the various proteins. Substrates for cell adhesion were prepared by incubating 3 ml of protein for 3 h followed by washes and blocking with BSA as previously described . When double coating was used, Ig-fusion proteins were applied before the blocking step.
